Turkish Journal of Surgery

Turkish Journal of Surgery

ISSN: 2564-6850
e-ISSN: 2564-7032


Hasan Uzer, Hızır Akyıldız, Erdoğan Sözüer, Alper Akcan, Bahadır Öz

Department of General Surgery, Erciyes University School of Medicine, Kayseri, Turkey

Keywords: Rectal cancer, E2F1, prognosis


Objective: To evaluate whether E2F transcription factor 1 is a potential prognostic marker in patients with rectal cancer.
Material and Methods: Eighty-two patients who were treated with curative resection because of rectal cancer in the Erciyes University School of Medicine, Department of General Surgery were included in the study and analyzed retrospectively. Data were obtained from patient files, pathology reports, and hospital information system. Nuclear and cytoplasmic staining of E2F transcription factor 1 was performed for immunohistochemical analysis on paraffin-embedded and blocked tumor tissue samples of patients. The findings of the study were assessed with using IBM Statistical Package for Social Sciences Statistics 20.
Result: In the 5-year follow-up period, 34 (41.5%) patients were alive. Local recurrence was identified in 7 patients. According to E2F transcription factor 1 nuclear staining, the average survival rate in patients was 60% for strong nuclear staining and 28% for weak nuclear staining. There was significant statistical difference between groups according to their degree of nuclear staining (p=0.017). When the patients were evaluated according to cytoplasmic staining with E2F transcription factor 1, the average overall survival rate of patients with positive E2F transcription factor 1 cytoplasmic staining was 48.0±4.6% versus 55.9±7.9% for patients without staining (p=0.408).
Conclusion: The survival rates are higher in rectal cancer patients with strong immunohistochemical nuclear staining of E2F transcription factor 1.

This study was presented at the 48th Congress of European Society for Surgical Research. 29 May-1 June 2013, İstanbul, Turkey.

Cite this paper as: Uzer H, Akyıldız H, Sözüer E, Akcan A, Öz B. Prognostic value of E2F1 in rectal cancer. Turk J Surg 2017; 33: 180-184.

Ethics Committee Approval

Ethics committee approval was received for this study from the ethics committee of Erciyes University.

Peer Review

Externally peer-reviewed.

Author Contributions

Concept - H.A.; Design - A.A.; Supervision - E.S.; Resource - B.Ö.; Materials - H.U.; Data Collection and/or Processing - H.U.; Analysis and/or Interpretation - H.U.; Literature Search - H.U.; Writing Manuscript - H.U.; Critical Reviews - H.A.

Conflict of Interest

No conflict of interest was declared by the authors.

Financial Disclosure

The authors declared that this study has received no financial support.